RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: chronic obstructive pulmonary disease
Accession: DOID:3083
browse the term
Definition: An obstructive lung disease that is a chronic and progressive disorder of small airways in the lungs and that is characterized by irreversible airflow obstruction, typically identified by reductions in quantitative spirometric indices, induced forced expiratory volume at 1 second (FEV1) and the ratio of FEV1 to forced vital capacity (less than 0.7 is diagnostic of COPD). Lung volume is increased and pulmonary hypertension may occur. The pathologic changes result in the disruption of the airflow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough and chest tightness. COPD is a consequence (an end result) of chronic bronchitis, emphysema or both. (DO)
Synonyms: exact_synonym: COAD; COLD; COPD; Chronic Airflow Obstruction; Chronic Airflow Obstructions; Chronic Obstructive Airway Disease; Chronic Obstructive Lung Disease
narrow_synonym: CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BIOMASS RELATED; COPD, severe early-onset; Chronic Obstructive Pulmonary Disease, Severe Early-Onset; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, RATE OF DECLINE OF LUNG FUNCTION IN
related_synonym: ANTICHYMOTRYPSIN BONN 1; HMOX1-RELATED CONDITION; chronic obstructive pulmonary disease, susceptibility to
primary_id: MESH:C564641 ; MESH:D029424
alt_id: DOID:9005540; MIM:606963
xref: EFO:0000341 ; ICD10CM:J44.9 ; NCI:C3199
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abcc1
ATP-binding cassette, sub-family C member 1
severity
ISO
DNA:SNPs: :rs212093, rs4148382 (human) mRNA:decreased expression:respiratory epithelial cell
RGD
PMID:20487524 PMID:12930913
RGD:5128824 , RGD:5128827
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
G
Ace
angiotensin I converting enzyme
susceptibility disease_progression
ISO
DNA:polymorphism (human)
RGD
PMID:20096799 PMID:20156752 PMID:19493329
RGD:4140487 , RGD:4140480 , RGD:4140912
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Adam33
a disintegrin and metallopeptidase domain 33
no_association susceptibility
ISO
DNA:polymorphisms: :multiple (human) DNA:polymorphisms (human)
RGD
PMID:19284602 PMID:20156753 PMID:20003279
RGD:4145361 , RGD:4145358 , RGD:4145357
NCBI chr 2:130,892,739...130,905,734
Ensembl chr 2:130,892,511...130,905,734
G
Adam9
ADAM metallopeptidase domain 9
ISO
protein:increased expression:pulmonary artery
RGD
PMID:36522710
RGD:401850545
NCBI chr 8:25,439,627...25,507,138
Ensembl chr 8:25,439,627...25,506,943
G
Adipoq
adiponectin, C1Q and collagen domain containing
disease_progression
ISO
associated with Metabolic Syndrome X;protein:decreased expression:serum
RGD
PMID:22207678 PMID:21179920
RGD:5686379 , RGD:5686825
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adora2a
adenosine A2a receptor
IDA
RGD
PMID:16339780
RGD:4890385
NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
G
Adrb1
adrenergic receptor, beta 1
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar RGD
PMID:10212248 PMID:12374873 PMID:16844790 PMID:17496726 PMID:11527135
RGD:5129114
NCBI chr19:56,710,549...56,713,582
Ensembl chr19:56,710,631...56,721,545
G
Adrb2
adrenergic receptor, beta 2
no_association severity disease_progression
ISO
DNA:SNPs: :rs1042717, rs1042718 (human) DNA:polymorphism: :p.Q27E (human) DNA:SNP: :p.R16G (human) DNA:SNPs: :p.R16G, p.Q27E (human) protein:decreased expression:blood, sputum, mononuclear cell
RGD
PMID:11527135 PMID:20525719 PMID:19293197 PMID:19747908 PMID:18667995 PMID:18789663 PMID:20211002 PMID:19080468 More...
RGD:5129114 , RGD:4140935 , RGD:4145082 , RGD:4145080 , RGD:4145095 , RGD:4145093 , RGD:4144899 , RGD:4145086
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
G
Ager
advanced glycosylation end product-specific receptor
ISO
ClinVar Annotator: match by term: COPD, severe early onset
ClinVar RGD
PMID:20133931
RGD:6767312
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Ang
angiogenin, ribonuclease, RNase A family, 5
ISO
protein:increased expression:sputum
RGD
PMID:21916917
RGD:6892708
NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466
G
Arnt2
aryl hydrocarbon receptor nuclear translocator 2
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr 7:83,895,486...84,059,201
Ensembl chr 7:83,895,486...84,059,384
G
Bambi
BMP and activin membrane-bound inhibitor
ISO
mRNA:increased expression:CD4+ T :
RGD
PMID:27549738
RGD:14390164
NCBI chr18:3,507,011...3,516,404
Ensembl chr18:3,507,923...3,516,404
G
Bcl2l1
BCL2-like 1
ISO
mRNA:increased expression:peripheral blood, neutrophil (human)
RGD
PMID:22686245
RGD:11353864
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bdkrb2
bradykinin receptor, beta 2
ISO
RGD
PMID:16600946
RGD:4890451
NCBI chr12:105,529,431...105,561,503
Ensembl chr12:105,529,485...105,561,496
G
Bmal2
basic helix-loop-helix ARNT like 2
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr 6:146,696,230...146,735,027
Ensembl chr 6:146,697,553...146,735,027
G
Bnip3
BCL2/adenovirus E1B interacting protein 3
treatment
ISO
RGD
PMID:25888379
RGD:11561985
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
G
C3
complement component 3
ISO
protein:increased expression:lung
RGD
PMID:17975205
RGD:5129504
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
C5ar1
complement component 5a receptor 1
ISO
protein:increased expression:lung, mast cell
RGD
PMID:19926870
RGD:5130165
NCBI chr 7:15,980,668...15,993,465
Ensembl chr 7:15,980,668...15,993,465
G
Casp12
caspase 12
treatment
ISO
RGD
PMID:24694971
RGD:13782182
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
G
Casp3
caspase 3
treatment
ISO
RGD
PMID:28496315
RGD:13782303
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
treatment
ISO
RGD
PMID:28496315
RGD:13782303
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cat
catalase
ISO
RGD
PMID:20080081
RGD:4293707
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccl1
C-C motif chemokine ligand 1
severity
ISO
DNA:SNP:enhancer:rs2282691 (human)
RGD
PMID:16864713
RGD:4891410
NCBI chr11:82,067,492...82,070,638
Ensembl chr11:82,067,483...82,196,516
G
Ccl11
C-C motif chemokine ligand 11
severity
ISO
RGD
PMID:19925666
RGD:4145389
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
G
Ccl17
C-C motif chemokine ligand 17
ISO
mRNA, protein:increased expression:respiratory system mucosa, respiratory system fluid/secretion
RGD
PMID:18684970
RGD:4145489
NCBI chr 8:95,535,996...95,538,666
Ensembl chr 8:95,537,081...95,538,664
G
Ccl2
C-C motif chemokine ligand 2
ISO
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:34652871 PMID:20497022
RGD:4891429
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl22
C-C motif chemokine ligand 22
ISO
mRNA, protein:increased expression:respiratory system mucosa, respiratory system fluid/secretion
RGD
PMID:18684970
RGD:4145489
NCBI chr 8:95,472,312...95,478,016
Ensembl chr 8:95,472,218...95,478,327
G
Ccl4
C-C motif chemokine ligand 4
ISO
RGD
PMID:17868461 PMID:11475557
RGD:5130900 , RGD:5130901
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
G
Ccl5
C-C motif chemokine ligand 5
ISO
mRNA, protein:increased expression:lung, bronchial epithelium, submucosa (human)
RGD
PMID:19703829
RGD:4891477
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccl7
C-C motif chemokine ligand 7
ISO
mRNA,protein:increased expression:macrophage
RGD
PMID:21327296
RGD:6483765
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
G
Ccl8
C-C motif chemokine ligand 8
ISO
RGD
PMID:20970515
RGD:5131087
NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
G
Ccn2
cellular communication network factor 2
ISO
mRNA, protein:increased expression:lung (rat)
RGD
PMID:19659652
RGD:2314483
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
G
Ccr3
C-C motif chemokine receptor 3
ISO
protein:increased expression:respiratory system fluid/secretion, neutrophil
RGD
PMID:19017998
RGD:4145632
NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
G
Ccr5
C-C motif chemokine receptor 5
ISO
protein:increased expression:blood (human)
RGD
PMID:19229703
RGD:4892070
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Cd28
CD28 antigen
ISO
CD28 null allele is increased in COPD
RGD
PMID:18057064 PMID:19220836
RGD:5131620 , RGD:5131618
NCBI chr 1:60,785,547...60,812,521
Ensembl chr 1:60,755,959...60,812,518
G
Cd40
CD40 antigen
severity
ISO
RGD
PMID:20699612
RGD:5490968
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd80
CD80 antigen
ISO
RGD
PMID:19729666
RGD:4892292
NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697
G
Cd86
CD86 antigen
severity susceptibility
ISO
protein:increased expression:lung, myeloid dendritic cell (human) DNA:polymorphism:cds:g.1057G>A rs1129055 (human)
RGD
PMID:19729666 PMID:20732370
RGD:4892292 , RGD:4891504
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
G
Cd8a
CD8 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17950725
NCBI chr 6:71,350,411...71,356,155
Ensembl chr 6:71,350,411...71,356,157
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35303175
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdkn2a
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35303175
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
G
Cftr
cystic fibrosis transmembrane conductance regulator
disease_progression
ISO
DNA:polymorphism:cds:p.M470V(human)
RGD
PMID:18652532
RGD:4140431
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
G
Chi3l1
chitinase 3 like 1
ISO
protein:increased secretion:serum (human)
RGD
PMID:20656949
RGD:4892658
NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919
G
Chrm3
cholinergic receptor, muscarinic 3, cardiac
ISO
RGD
PMID:19281093
RGD:5133441
NCBI chr13:9,925,522...10,411,131
Ensembl chr13:9,925,522...10,410,883
G
Chrna3
cholinergic receptor, nicotinic, alpha polypeptide 3
susceptibility disease_progression
ISO
associated with smoking; DNA:SNP::rs1051730(human) DNA:SNP: :rs12910984(human) DNA:SNP: :rs6495309(human) associated with smoking; DNA:SNP: :rs1051730(human)
RGD
PMID:29993116 PMID:23207642 PMID:23056235 PMID:22441734 PMID:26751916
RGD:150526806 , RGD:151347538 , RGD:151347536 , RGD:151347455 , RGD:150527850
NCBI chr 9:54,917,401...54,933,846
Ensembl chr 9:54,917,395...54,933,846
G
Chrna5
cholinergic receptor, nicotinic, alpha polypeptide 5
susceptibility
ISO
associated with lung cancer; DNA:SNP::rs16969968 (human) associated with smoking; DNA:SNP::rs16969968 (human)
RGD
PMID:33419953 PMID:29993116
RGD:150524357 , RGD:150526806
NCBI chr 9:54,888,112...54,918,704
Ensembl chr 9:54,888,164...54,915,063
G
Chrna7
cholinergic receptor, nicotinic, alpha polypeptide 7
disease_progression
ISO
DNA:CNV:: CNV-3956(human)
RGD
PMID:25407004
RGD:11074492
NCBI chr 7:62,748,440...62,862,274
Ensembl chr 7:62,748,440...62,862,317
G
Chrnb4
cholinergic receptor, nicotinic, beta polypeptide 4
ISO
ClinVar Annotator: match by term: Chronic obstructive pulmonary disease
ClinVar
NCBI chr 9:54,935,438...54,956,236
Ensembl chr 9:54,935,438...54,956,063
G
Clca1
chloride channel accessory 1
severity
ISO
mRNA:increased expression:bronchus DNA:SNPs: :multiple (human)
RGD
PMID:17637221 PMID:14985398
RGD:4145655 , RGD:1331524
NCBI chr 3:144,710,298...144,738,537
Ensembl chr 3:144,709,578...144,738,537
G
Cma1
chymase 1, mast cell
ISO
protein:increased expression:respiratory tract epithelium, mast cell (human)
RGD
PMID:18783610
RGD:5128552
NCBI chr14:56,178,908...56,182,132
Ensembl chr14:56,178,908...56,182,132
G
Col1a1
collagen, type I, alpha 1
ISO
RGD
PMID:15469929
RGD:5131854
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Crhr1
corticotropin releasing hormone receptor 1
treatment
ISO
DNA:SNP:intron: (rs242941) (human)
RGD
PMID:19210659
RGD:11097322
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
G
Crp
C-reactive protein, pentraxin-related
severity
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29329563 PMID:21506665 PMID:21468168
RGD:5131278 , RGD:5131279
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
ISO
protein:increased expression:sputum
RGD
PMID:19213775
RGD:5131476
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
DNA:SNP: :-318C>T (rs5742909) (human)
RGD
PMID:21129004 PMID:20732370
RGD:4891499 , RGD:4891504
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23099361 PMID:20858153
RGD:4890939
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
protein:increased expression:sputum
RGD
PMID:17925429
RGD:5135436
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl11
chemokine (C-X-C motif) ligand 11
ISO
protein:increased expression:sputum
RGD
PMID:17925429
RGD:5135436
NCBI chr 5:92,507,403...92,511,155
Ensembl chr 5:92,507,403...92,513,344
G
Cxcl15
C-X-C motif chemokine ligand 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15337792 PMID:23099361 PMID:28864214
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23099361
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23099361
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cxcl5
C-X-C motif chemokine ligand 5
severity
ISO
RGD
PMID:12857718
RGD:5135248
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
protein:increased expression:sputum
RGD
PMID:19229703 PMID:17925429
RGD:4892070 , RGD:5135436
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
G
Cxcr2
C-X-C motif chemokine receptor 2
severity
ISO
RGD
PMID:12857718
RGD:5135248
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
G
Cxcr3
C-X-C motif chemokine receptor 3
disease_progression
ISO
protein:increased expression:respiratory system fluid/secretion, neutrophil
RGD
PMID:19218194 PMID:19017998
RGD:5135435 , RGD:4145632
NCBI chr X:100,775,141...100,777,753
Ensembl chr X:100,775,141...100,777,875
G
Cyba
cytochrome b-245, alpha polypeptide
susceptibility
ISO
DNA:polymorphisms: :-930A>G, 242C>T (human) DNA:polymorphism: :p.H72Y (human)
RGD
PMID:20080081 PMID:19567155
RGD:4293707 , RGD:4304108
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
no_association severity susceptibility
ISO
DNA:polymorphisms: :2455A>G, 3801T>C (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism (human) DNA:polymorphisms: :p.I462V, 3801T>C (human)
CTD RGD
PMID:19022366 PMID:18389617 PMID:19507017 PMID:20080081
RGD:4892071 , RGD:4892045 , RGD:4293707
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
susceptibility
ISO
DNA:polymorphisms: :-3860G>A (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20797314 PMID:20080081
RGD:4293707
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp2c29
cytochrome P450, family 2, subfamily c, polypeptide 29
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
G
Cyp2c65
cytochrome P450, family 2, subfamily c, polypeptide 65
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
DNA:polymorphisms: :-1293G>C, 7632T>A, 9893C>G (human)
RGD
PMID:17442289
RGD:4892219
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp2j9
cytochrome P450, family 2, subfamily j, polypeptide 9
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 7:114,149,358...114,162,283
Ensembl chr 7:114,148,917...114,162,207
G
Cyp46a1
cytochrome P450, family 46, subfamily a, polypeptide 1
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr12:108,300,568...108,328,497
Ensembl chr12:108,300,640...108,328,493
G
Cyp4a31
cytochrome P450, family 4, subfamily a, polypeptide 31
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr 4:115,420,824...115,436,212
Ensembl chr 4:115,420,846...115,436,212
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr 4:115,481,895...115,504,918
Ensembl chr 4:115,481,922...115,504,920
G
Ddit3
DNA-damage inducible transcript 3
treatment
ISO
RGD
PMID:24694971
RGD:13782182
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Defb1
defensin beta 1
susceptibility no_association
ISO
DNA:polymorphism: :668C>G (human) DNA:SNPs: :multiple (human) DNA:polymorphism (human)
RGD
PMID:15569478 PMID:16700921 PMID:11829455
RGD:4892257 , RGD:4892251 , RGD:1331523
NCBI chr 8:22,266,571...22,285,201
Ensembl chr 8:22,266,615...22,285,201
G
Dsp
desmoplakin
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Chronic obstructive pulmonary disease
CTD ClinVar
PMID:28166215
NCBI chr13:38,335,357...38,382,553
Ensembl chr13:38,335,270...38,382,553
G
Edn1
endothelin 1
ISO
DNA:insertion, transversion:5' utr, exon:c.138_139insA, p.K198N (human) protein:increased expression:sputum (human)
RGD
PMID:20707291 PMID:10445603
RGD:4144868 , RGD:4145062
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Eefsec
eukaryotic elongation factor, selenocysteine-tRNA-specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28166215
NCBI chr 6:88,234,318...88,423,489
Ensembl chr 6:88,234,316...88,423,521
G
Egfr
epidermal growth factor receptor
ISO
protein:increased expression:bronchial epithelium (human)
RGD
PMID:16393673 PMID:22732689
RGD:5131627 , RGD:7204496
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Egr1
early growth response 1
IMP ISO
associated with Tobacco Use Disorder associated with Tobacco Use Disorder;mRNA:increased expression:lung (human)
RGD
PMID:20417178 PMID:15469929
RGD:5131878 , RGD:5131854
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
G
Eln
elastin
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25106431 PMID:16081882
RGD:1580326
NCBI chr 5:134,731,449...134,776,300
Ensembl chr 5:134,731,447...134,776,177
G
Ephx1
epoxide hydrolase 1, microsomal
no_association susceptibility
ISO
DNA:SNPs:exons:p.Y113H (rs1051740), p.H139R (rs2234922) (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism DNA:SNP:exon:p.H139R (rs2234922) (human) DNA:SNPs: :multiple (human)
CTD RGD
PMID:9288046 PMID:17564249 PMID:18811882 PMID:9288046 PMID:20932192 PMID:18614560 More...
RGD:4889123 , RGD:4889121 , RGD:1601065 , RGD:4889120 , RGD:4889122
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Erbb3
erb-b2 receptor tyrosine kinase 3
ISO
protein:increased expression:lung
RGD
PMID:17908459
RGD:2289953
NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521
G
F2
coagulation factor II
severity
ISO
RGD
PMID:21660493
RGD:5147752
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
F2rl1
F2R like trypsin receptor 1
ISO
RGD
PMID:21245013
RGD:4892586
NCBI chr13:95,648,226...95,661,748
Ensembl chr13:95,648,240...95,661,735
G
Faim2
Fas apoptotic inhibitory molecule 2
ISO
RGD
PMID:29208459
RGD:13792601
NCBI chr15:99,394,886...99,432,757
Ensembl chr15:99,394,893...99,426,046
G
Fam13a
family with sequence similarity 13, member A
susceptibility
ISO
DNA:SNP: :rs7671167 (human) ClinVar Annotator: match by term: Chronic obstructive pulmonary disease CTD Direct Evidence: marker/mechanism
ClinVar CTD RGD
PMID:20173748 PMID:28166215 PMID:25928290
RGD:11552597
NCBI chr 6:58,910,521...59,001,487
Ensembl chr 6:58,909,075...59,001,534
G
Fas
Fas cell surface death receptor
ISO
RGD
PMID:29208459
RGD:13792601
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fasl
Fas ligand
ISO
RGD
PMID:29208459
RGD:13792601
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Flt1
FMS-like tyrosine kinase 1
ISO
protein:increased expression:lung
RGD
PMID:15681497
RGD:5684420
NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
G
Foxo3
forkhead box O3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23099361
NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751
G
Gc
vitamin D binding protein
ISO
ClinVar Annotator: match by term: Chronic obstructive pulmonary disease
ClinVar RGD
PMID:28492532 PMID:9517617 PMID:15118671
RGD:5509932 , RGD:1331525
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
Grik5
glutamate receptor, ionotropic, kainate 5 (gamma 2)
susceptibility
ISO
DNA:SNP: :rs8099939
RGD
PMID:28900078
RGD:401900295
NCBI chr 7:24,709,274...24,775,421
Ensembl chr 7:24,709,274...24,771,771
G
Grin2b
glutamate receptor, ionotropic, NMDA2B (epsilon 2)
susceptibility
ISO
DNA:SNP: :rs2268132
RGD
PMID:28900078
RGD:401900295
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
G
Gstm1
glutathione S-transferase, mu 1
susceptibility resistance
ISO
DNA:deletion: : mRNA:decreased expression:lung associated with Carcinoma, Non-Small-Cell Lung;
RGD
PMID:19664521 PMID:16919984 PMID:15038404
RGD:4140939 , RGD:4142517 , RGD:4142538
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstp1
glutathione S-transferase, pi 1
susceptibility no_association
ISO
mRNA:decreased expression:lung ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to DNA:polymorphism:exon:p.I105V (human) DNA:SNPs: :p.I105V, p.A114V (human)
ClinVar RGD
PMID:25741868 PMID:16919984 PMID:20467983 PMID:17532303 PMID:17439673
RGD:4142517 , RGD:4140938 , RGD:4142511 , RGD:4142514
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Gstt1
glutathione S-transferase, theta 1
susceptibility
ISO
associated with GSTM1 null mutation; DNA:deletion: :
RGD
PMID:19664521 PMID:20402821
RGD:4140939 , RGD:4140928
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
Gzma
granzyme A
ISO
RGD
PMID:20047264
RGD:5135520
NCBI chr13:113,230,358...113,237,515
Ensembl chr13:113,230,359...113,237,515
G
Gzmb
granzyme B
ISO
RGD
PMID:20540777
RGD:5135516
NCBI chr14:56,496,293...56,499,791
Ensembl chr14:56,496,295...56,499,717
G
Hc
hemolytic complement
severity
ISO
protein:increased expression:sputum
RGD
PMID:20500690
RGD:5129705
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
G
Hdac2
histone deacetylase 2
treatment
ISO
protein:decreased expression:lung: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15337792 PMID:18421014 PMID:22732689 PMID:24940433
RGD:7204496 , RGD:9590287
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
G
Hdac8
histone deacetylase 8
severity
ISO
mRNA:decreased expression:lung (human)
RGD
PMID:15888697
RGD:13208820
NCBI chr X:101,328,244...101,549,005
Ensembl chr X:101,328,245...101,548,965
G
Hhip
Hedgehog-interacting protein
susceptibility
ISO
DNA:SNPs: :rs11100865, rs7654947(human) ClinVar Annotator: match by term: Chronic obstructive pulmonary disease, biomass related DNA:SNP: :rs13118928(human)
ClinVar RGD
PMID:25928290 PMID:19996190
RGD:11552597 , RGD:11552598
NCBI chr 8:80,692,480...80,784,637
Ensembl chr 8:80,692,480...80,784,635
G
Hif1a
hypoxia inducible factor 1, alpha subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26752192
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hmox1
heme oxygenase 1
susceptibility treatment severity
ISO
DNA:polymorphism:promoter ClinVar Annotator: match by term: Chronic obstructive pulmonary disease | ClinVar Annotator: match by term: HMOX1-related condition | ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, severe early-onset CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:9884342 PMID:21088618 PMID:25741868 PMID:28492532 PMID:17203192 PMID:20705587 PMID:17254481 More...
RGD:4145372 , RGD:10755705 , RGD:4145371
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hp
haptoglobin
ISO
RGD
PMID:21471098
RGD:5144151
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Hspa1a
heat shock protein 1A
ISO
ClinVar Annotator: match by term: Chronic obstructive pulmonary disease
ClinVar
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
G
Hspa1b
heat shock protein 1B
ISO
ClinVar Annotator: match by term: Chronic obstructive pulmonary disease
ClinVar
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
G
Hspa1l
heat shock protein 1-like
ISO
ClinVar Annotator: match by term: Chronic obstructive pulmonary disease
ClinVar
NCBI chr17:35,191,679...35,198,204
Ensembl chr17:35,191,679...35,198,261
G
Hspa4
heat shock protein 4
no_association
ISO
protein:increased expression:serum (human) protein:increased expression:bronchial mucosa (human)
RGD
PMID:19350847 PMID:22140545
RGD:5688779 , RGD:5688781
NCBI chr11:53,150,641...53,191,306
Ensembl chr11:53,150,641...53,191,284
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs6313
CTD RGD
PMID:22048642 PMID:28900078
RGD:401900295
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
Hykk
hydroxylysine kinase 1
ISO
ClinVar Annotator: match by term: Chronic obstructive pulmonary disease
ClinVar
NCBI chr 9:54,824,574...54,857,208
Ensembl chr 9:54,824,567...54,857,208
G
Icam1
intercellular adhesion molecule 1
ISO IEP
mRNA:increased expression:airway epithelial cell (human) CTD Direct Evidence: marker/mechanism protein:decreased expression:airway epithelium (mouse)
CTD RGD
PMID:29329563 PMID:20395558 PMID:18794286
RGD:4145446 , RGD:4145522
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Il12b
interleukin 12b
ISO
DNA:polymorphism: :
RGD
PMID:19279357
RGD:4145423
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il13
interleukin 13
susceptibility no_association
ISO
DNA:polymorphism:promoter:c.-1055C>T (human) DNA:polymorphisms:intron1,exon4s: rs2066960, rs20541, rs1295685 (human) DNA:SNP:promoter:c.-1055 C>T (human) DNA:polymorphism: :c. 1103C>T (human)
RGD
PMID:19995275 PMID:19796199 PMID:15820084 PMID:15308043
RGD:4145596 , RGD:4145601 , RGD:4145714 , RGD:4145668
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il13ra1
interleukin 13 receptor, alpha 1
ISO
DNA:SNP: :rs2250747 (human)
RGD
PMID:19796199
RGD:4145601
NCBI chr X:35,375,761...35,434,915
Ensembl chr X:35,375,763...35,434,912
G
Il16
interleukin 16
ISO
protein:increased expression:lung
RGD
PMID:20079227
RGD:5024924
NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934
G
Il17a
interleukin 17A
ISO
protein:increased expression:respiratory mucosa protein:increased expression:lung, bronchioalveolar lavage fluid (rat)
RGD
PMID:19604272 PMID:16200865
RGD:4889104 , RGD:9068943
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il18
interleukin 18
ISO
protein:increased expression:serum protein:increased expression:sputum, macrophage
RGD
PMID:20026745 PMID:19208460
RGD:4889551 , RGD:4889575
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il18bp
interleukin 18 binding protein
ISO
protein:increased expression:serum
RGD
PMID:20026745
RGD:4889551
NCBI chr 7:101,664,281...101,669,699
Ensembl chr 7:101,664,092...101,667,897
G
Il1b
interleukin 1 beta
no_association susceptibility severity
ISO
DNA:polymorphism: :-31T>C (human) DNA:polymorphisms: :-31T>C, 3954T>C (human) DNA:polymorphisms: :-31T>C, 3953T>C (human) DNA:polymorphisms: :-31T>C, -511C>T (human)
RGD
PMID:18364273 PMID:15766560 PMID:17380888 PMID:18579366
RGD:4142868 , RGD:4143169 , RGD:4142873 , RGD:4142866
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rl1
interleukin 1 receptor-like 1
ISO IEP
mRNA:increased expression:lung:
RGD
PMID:19927353 PMID:30952808
RGD:5144227 , RGD:40400740
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Il1rn
interleukin 1 receptor antagonist
susceptibility no_association
ISO
DNA:polymorphism:intron (human) protein:decreased expression:plasma DNA:polymorphism (human)
RGD
PMID:18579366 PMID:19291375 PMID:18364273
RGD:4142866 , RGD:4142861 , RGD:4142868
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il27
interleukin 27
ISO
DNA:polymorphisms: :-964A>G, 2905T>G (human)
RGD
PMID:18554158
RGD:5128484
NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113
G
Il33
interleukin 33
IEP
mRNA,protein:increased expression:lung:
RGD
PMID:30952808
RGD:40400740
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Il5
interleukin 5
ISO
protein:increased expression:serum
RGD
PMID:20858153
RGD:4890939
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
G
Il5ra
interleukin 5 receptor, alpha
ISO
protein:increased expression:serum
RGD
PMID:15286446
RGD:5128619
NCBI chr 6:106,687,336...106,725,998
Ensembl chr 6:106,687,318...106,725,998
G
Il6
interleukin 6
ISO
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28864214 PMID:29329563 PMID:31349846 PMID:20819268
RGD:4143243
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il9
interleukin 9
ISO
protein:increased expression:sputum, macrophage, cytoplasm
RGD
PMID:15303135
RGD:5128691
NCBI chr13:56,627,090...56,630,070
Ensembl chr13:56,627,090...56,630,059
G
Jun
jun proto-oncogene
IEP
mRNA, protein:increased expression:lung (mouse)
RGD
PMID:34331613
RGD:155663371
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Kdr
kinase insert domain protein receptor
ISO
protein:increased expression:lung
RGD
PMID:15681497
RGD:5684420
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Klf5
Kruppel-like transcription factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30639269
NCBI chr14:99,536,127...99,550,848
Ensembl chr14:99,536,127...99,552,472
G
Lcn3
lipocalin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28381600
NCBI chr 2:25,655,545...25,658,110
Ensembl chr 2:25,655,581...25,658,111
G
Lep
leptin
severity
ISO
DNA:polymorphism:promoter: -2548 G>A (human) protein:decreased expression:serum protein:increased expression:plasma
RGD
PMID:20854423 PMID:20021311 PMID:21367591
RGD:5128777 , RGD:5128778 , RGD:5128772
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lepr
leptin receptor
disease_progression
ISO
protein:decreased expression:lung DNA:SNPs: :
RGD
PMID:19196818 PMID:19196818
RGD:5128813 , RGD:5128813
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
G
Lrp1b
low density lipoprotein-related protein 1B
susceptibility
ISO
associated with lung adenocarcinoma;DNA:mutations:multiple: (human)
RGD
PMID:28522810
RGD:150429784
NCBI chr 2:40,485,302...42,543,747
Ensembl chr 2:40,485,258...42,543,636
G
Map2k4
mitogen-activated protein kinase kinase 4
severity
ISO
RGD
PMID:20699612
RGD:5490968
NCBI chr11:65,579,070...65,679,185
Ensembl chr11:65,579,069...65,679,123
G
Map3k7
mitogen-activated protein kinase kinase kinase 7
IEP
mRNA, protein:increased expression:lung (mouse)
RGD
PMID:34331613
RGD:155663371
NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467
G
Mapk8
mitogen-activated protein kinase 8
severity
ISO IEP
mRNA, protein:increased expression:lung (mouse)
RGD
PMID:20699612 PMID:34331613
RGD:5490968 , RGD:155663371
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mbl2
mannose-binding lectin (protein C) 2
ISO
DNA:polymorphisms:5' utr, exon:multiple (human) protein:decreased secretion:lung (human)
RGD
PMID:20688922 PMID:19411612
RGD:4889421 , RGD:4889448
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Mcam
melanoma cell adhesion molecule
ISO
RGD
PMID:23649916
RGD:7364780
NCBI chr 9:44,045,958...44,054,024
Ensembl chr 9:44,045,766...44,054,024
G
Mgst1
microsomal glutathione S-transferase 1
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr 6:138,117,525...138,133,753
Ensembl chr 6:138,117,314...138,133,753
G
Mgst3
microsomal glutathione S-transferase 3
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
NCBI chr 1:167,199,535...167,221,410
Ensembl chr 1:167,199,535...167,221,410
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26752192
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
G
Mir126a
microRNA 126a
ISO
RNA:decreased expression:lung
RGD
PMID:36522710
RGD:401850545
NCBI chr 2:26,481,369...26,481,441
Ensembl chr 2:26,481,369...26,481,441
G
Mir210
microRNA 210
disease_progression
ISO
associated with lung cancer;miRNA:decreased expression: peripheral blood (human) associated with cerebral infarction;miRNA:decreased expression: peripheral blood (human)
RGD
PMID:28745794 PMID:27906445
RGD:155598593 , RGD:155598676
NCBI chr 7:140,801,297...140,801,406
Ensembl chr 7:140,801,297...140,801,406
G
Mir218-2
microRNA 218-2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28864214
NCBI chr11:35,507,643...35,507,752
Ensembl chr11:35,507,643...35,507,752
G
Mmp14
matrix metallopeptidase 14 (membrane-inserted)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19661247
NCBI chr14:54,669,055...54,679,913
Ensembl chr14:54,669,069...54,682,821
G
Mmp1a
matrix metallopeptidase 1a (interstitial collagenase)
ISO
mRNA:increased expression:bone (rat)
RGD
PMID:23173262
RGD:7207216
NCBI chr 9:7,464,141...7,476,870
Ensembl chr 9:7,464,141...7,476,857
G
Mmp1b
matrix metallopeptidase 1b (interstitial collagenase)
ISO
ClinVar Annotator: match by term: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, RATE OF DECLINE OF LUNG FUNCTION IN | ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, severe early-onset
ClinVar
PMID:9850057 PMID:11741975 PMID:11875051 PMID:18030675 PMID:25741868 PMID:28492532 More...
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
G
Mmp9
matrix metallopeptidase 9
treatment susceptibility severity
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism DNA:polymorphism: :-1562C-->T (human) DNA:polymorphism:promoter:-1562C-->T (human)
CTD RGD
PMID:19299917 PMID:19411568 PMID:25842729 PMID:20160424 PMID:18619044
RGD:5129553 , RGD:13207319 , RGD:5129494 , RGD:5130149
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mpo
myeloperoxidase
severity
ISO
protein:increased activity:plasma protein:increased expression:serum
RGD
PMID:19491038 PMID:10917466
RGD:5130997 , RGD:5130993
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Mtcl1
microtubule crosslinking factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28166215
NCBI chr17:66,643,975...66,760,672
Ensembl chr17:66,643,977...66,756,745
G
Muc1
mucin 1, transmembrane
ISO
protein:increased expression:sputum (human)
RGD
PMID:21474912
RGD:5131160
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
treatment
ISO
mRNA, protein:increased expression:lung protein:increased expression:bronchi
RGD
PMID:17637221 PMID:22282955 PMID:19723147
RGD:4145655 , RGD:7349406 , RGD:5131190
NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
G
Muc5b
mucin 5, subtype B, tracheobronchial
ISO
protein:increased expression:sputum
RGD
PMID:18776153
RGD:5131169
NCBI chr 7:141,392,796...141,426,826
Ensembl chr 7:141,392,807...141,426,821
G
Nat2
N-acetyltransferase 2 (arylamine N-acetyltransferase)
susceptibility
ISO
DNA:polymorphisms: :
RGD
PMID:17442289 PMID:12884528
RGD:4892219 , RGD:5131863
NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
ISO
protein:decreased expression:lung protein:increased expression:lung
RGD
PMID:18556627 PMID:22737924
RGD:5134980 , RGD:10412732
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nod2
nucleotide-binding oligomerization domain containing 2
severity
ISO
DNA:SNP:intron: (rs1077861) (human)
RGD
PMID:21943069
RGD:5508720
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
G
Nos1
nitric oxide synthase 1, neuronal
severity
ISO
protein:increased expression:skeletal muscle mRNA, protein:increased expression:lung
RGD
PMID:12816735 PMID:19797159
RGD:5132628 , RGD:5132607
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
Nos2
nitric oxide synthase 2, inducible
ISO
protein:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21843929 PMID:12797490
RGD:4891444
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21843929
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment susceptibility
ISO IEP
protein, mRNA:decreased expression:lung DNA:polymorphisms: :465C>T, 609C>T (human)
RGD
PMID:18556627 PMID:28790194 PMID:19705749
RGD:5134980 , RGD:13439712 , RGD:5133267
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
protein:decreased expression:lung, lymphocyte
RGD
PMID:20450542 PMID:9926163
RGD:4892318 , RGD:4892564
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Ntf3
neurotrophin 3
ISO
mRNA:decreased expression:bronchus
RGD
PMID:15843147
RGD:4891120
NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873
G
Ntrk1
neurotrophic tyrosine kinase, receptor, type 1
ISO
protein:increased expression:bronchiolar epithelial cell
RGD
PMID:21429417
RGD:5684530
NCBI chr 3:87,685,551...87,702,549
Ensembl chr 3:87,685,551...87,702,469
G
Pde3b
phosphodiesterase 3B, cGMP-inhibited
ISO
ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 7:114,014,388...114,137,173
Ensembl chr 7:114,014,516...114,138,486
G
Plau
plasminogen activator, urokinase
severity
ISO
proteine:increased expression:sputum, neutrophil
RGD
PMID:20624254 PMID:17651644
RGD:6483803 , RGD:6484146
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Plaur
plasminogen activator, urokinase receptor
ISO
protein:increased expression:bronchus
RGD
PMID:17651644
RGD:6484146
NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393
G
Pon1
paraoxonase 1
ISO
protein:decreased activity:serum (human)
RGD
PMID:16380766
RGD:8547571
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
ISO
RGD
PMID:20732852
RGD:6484530
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
DNA:polymorphism: :g.-765G>C (human) protein:increased expression:sputum
RGD
PMID:21655952 PMID:15949313
RGD:5135277 , RGD:5143926
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Rapgef3
Rap guanine nucleotide exchange factor (GEF) 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22363678
NCBI chr15:97,637,886...97,666,300
Ensembl chr15:97,642,651...97,665,853
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
IEP
mRNA, protein:increased expression:lung (mouse)
RGD
PMID:34331613
RGD:155663371
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Rnasel
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent)
IMP
RGD
PMID:23913960
RGD:40902622
NCBI chr 1:153,625,089...153,644,441
Ensembl chr 1:153,625,172...153,639,967
G
Rtel1
regulator of telomere elongation helicase 1
ameliorates
ISO
DNA:SNP:cds:rs4809324 (human)
RGD
PMID:28360516
RGD:152985694
NCBI chr 2:180,961,504...180,998,409
Ensembl chr 2:180,961,532...180,998,409
G
Scgb1a1
secretoglobin, family 1A, member 1
ISO
ClinVar Annotator: match by term: Chronic obstructive pulmonary disease
ClinVar
NCBI chr19:9,061,006...9,065,320
Ensembl chr19:9,061,000...9,065,322
G
Selp
selectin, platelet
severity
ISO
protein:increased expression:plasma
RGD
PMID:20646456
RGD:6478682
NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595
G
Serpina3b
serine (or cysteine) peptidase inhibitor, clade A, member 3B
susceptibility
ISO
DNA:polymorphism:exon:p.A-15T (human) ClinVar Annotator: match by term: ANTICHYMOTRYPSIN BONN 1
RGD ClinVar
PMID:1351206 PMID:8102759 PMID:8244391 PMID:10849024 PMID:25741868
RGD:5147441
NCBI chr12:104,094,245...104,105,805
Ensembl chr12:104,094,255...104,105,804
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
susceptibility
ISO
protein:increased expression:plasma DNA:missense mutations:Cds:p.L55P, P229A DNA:polymorphism:exon:p.A-15T (human)
RGD
PMID:17261175 PMID:8244391 PMID:10849024
RGD:5147433 , RGD:5147449 , RGD:5147441
NCBI chr12:104,372,967...104,380,588
Ensembl chr12:104,372,988...104,380,588
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
ISO
protein:increased expression:bronchus
RGD
PMID:11929177 PMID:17651644
RGD:4144041 , RGD:6484146
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Sftpa1
surfactant associated protein A1
susceptibility
ISO
protein:increased expression:lung DNA:SNP:cds:p.L50V (human) DNA:polymorphism:cds:c.186G>A (human)
RGD
PMID:19367700 PMID:19797132 PMID:11589345
RGD:4143288 , RGD:4143281 , RGD:4143423
NCBI chr14:40,853,745...40,858,330
Ensembl chr14:40,853,739...40,858,409
G
Sftpb
surfactant associated protein B
susceptibility severity
ISO
DNA:polymorphism: :1580C>T (human) DNA:SNP: :p.T131I (rs1130866) (human) DNA:SNPs: :multiple (human)
RGD
PMID:15315329 PMID:15817713 PMID:11589345 PMID:18550614
RGD:4143402 , RGD:4143396 , RGD:4143423 , RGD:4143290
NCBI chr 6:72,281,594...72,291,354
Ensembl chr 6:72,281,594...72,291,354
G
Sftpc
surfactant associated protein C
disease_progression
ISO
DNA:polymorphism: :186A>G (human)
RGD
PMID:18038590
RGD:4144115
NCBI chr14:70,758,381...70,761,521
Ensembl chr14:70,758,389...70,761,521
G
Sftpd
surfactant associated protein D
susceptibility severity
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: :p.A160T (human) DNA:SNPs: :multiple (human) protein:increased expression:serum
CTD RGD
PMID:28166215 PMID:18310480 PMID:19797132 PMID:20448057 PMID:20075511
RGD:4143501 , RGD:4143281 , RGD:4143487 , RGD:4143492
NCBI chr14:40,894,169...40,907,155
Ensembl chr14:40,894,171...40,907,106
G
Slc22a4
solute carrier family 22 (organic cation transporter), member 4
treatment
ISO
RGD
PMID:32707498
RGD:597538521
NCBI chr11:53,873,941...53,920,866
Ensembl chr11:53,873,949...53,918,916
G
Slc22a5
solute carrier family 22 (organic cation transporter), member 5
treatment
ISO
RGD
PMID:32707498
RGD:597538521
NCBI chr11:53,755,368...53,782,609
Ensembl chr11:53,755,368...53,782,486
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
susceptibility
ISO
DNA:SNP: :rs2020936 (human)
RGD
PMID:20981038
RGD:4889426
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Slpi
secretory leukocyte peptidase inhibitor
treatment
ISO
RGD
PMID:18375249
RGD:9999419
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
G
Smad4
SMAD family member 4
treatment
ISO
RGD
PMID:18375249
RGD:9999419
NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851
G
Smpd3
sphingomyelin phosphodiesterase 3, neutral
ISO
protein:increased expression:lung:
RGD
PMID:20448054
RGD:10041059
NCBI chr 8:106,979,180...107,064,597
Ensembl chr 8:106,979,180...107,064,620
G
Sod3
superoxide dismutase 3, extracellular
susceptibility
ISO
DNA:polymorphism: :p.R213G (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16399992 PMID:16467073 PMID:16399992
RGD:1581270 , RGD:1581270
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
G
Stat4
signal transducer and activator of transcription 4
ISO
protein:increased expression:lung
RGD
PMID:24321062
RGD:8661725
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Sting1
stimulator of interferon response cGAMP interactor 1
IEP
associated with Haemophilus Infections;mRNA, protein:increased expression:lung (mouse)
RGD
PMID:29421524
RGD:39128228
NCBI chr18:35,866,731...35,873,607
Ensembl chr18:35,866,732...35,873,607
G
Tab2
TGF-beta activated kinase 1/MAP3K7 binding protein 2
IEP
mRNA, protein:increased expression:lung (mouse)
RGD
PMID:34331613
RGD:155663371
NCBI chr10:7,781,412...7,832,039
Ensembl chr10:7,781,417...7,831,994
G
Tert
telomerase reverse transcriptase
ISO
ClinVar Annotator: match by term: Chronic obstructive pulmonary disease
ClinVar
PMID:25346280 PMID:25741868 PMID:28492532 PMID:30523342 PMID:30791107
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
G
Tgfb1
transforming growth factor, beta 1
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :509C>T, 869T>C (human) DNA:SNP:exon:869T>C (human)
CTD RGD
PMID:16365456 PMID:31349846 PMID:18269849 PMID:19186046 PMID:20193474
RGD:4145292 , RGD:4145140 , RGD:4145115
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Timp1
tissue inhibitor of metalloproteinase 1
treatment
ISO
RGD
PMID:25842729
RGD:13207319
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Tlr4
toll-like receptor 4
susceptibility
ISO
decreased expression:protein:monocyte ClinVar Annotator: match by term: Pulmonary disease, chronic obstructive, severe early-onset DNA:polymorphism:blood cells
ClinVar RGD
PMID:10835634 PMID:12124407 PMID:15547160 PMID:15829498 PMID:16879199 PMID:17704786 PMID:25741868 PMID:26079505 PMID:26174031 PMID:19080469 PMID:20169003 More...
RGD:4144145 , RGD:4144119
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
no_association disease_progression
ISO
DNA:SNPs:promoter CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter DNA:polymorphism: :c. 489G>A (human) protein:increased expression:sputum protein:increased expression:serum DNA:SNP:promoter:c.-308 G>A (human) DNA;polymorphism: :rs361525 (human)
CTD RGD
PMID:15337792 PMID:29497291 PMID:34652871 PMID:20352242 PMID:11179116 PMID:12537602 PMID:8564092 PMID:20500811 PMID:15820084 PMID:20299531 More...
RGD:4143273 , RGD:4143424 , RGD:4143421 , RGD:4143270 , RGD:4143272 , RGD:4145714 , RGD:4143391
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
severity
ISO
protein:increased expression:plasma (human)
RGD
PMID:19643942
RGD:5131203
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
severity
ISO
protein:increased expression:sputum (human)
RGD
PMID:21037022
RGD:5131154
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Tnfrsf8
tumor necrosis factor receptor superfamily, member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29984229
NCBI chr 4:144,993,702...145,041,734
Ensembl chr 4:144,993,707...145,041,734
G
Tnfsf8
tumor necrosis factor (ligand) superfamily, member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29984229
NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584
G
Tnnt2
troponin T2, cardiac
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18068611
NCBI chr 1:135,763,933...135,780,006
Ensembl chr 1:135,764,092...135,779,998
G
Tollip
toll interacting protein
ISO
ClinVar Annotator: match by term: Chronic obstructive pulmonary disease
ClinVar
NCBI chr 7:141,435,317...141,456,198
Ensembl chr 7:141,428,550...141,472,244
G
Trp53
transformation related protein 53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17274270
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21245013
NCBI chr 5:114,760,213...114,796,497
Ensembl chr 5:114,760,213...114,796,482
G
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
ISO
ClinVar Annotator: match by term: Chronic obstructive pulmonary disease
ClinVar
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
protein:increased expression:lung
RGD
PMID:15681497 PMID:20705587
RGD:5684420 , RGD:10755705
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Xrcc5
X-ray repair complementing defective repair in Chinese hamster cells 5
susceptibility
ISO
DNA:SNPs:multiple (human)
RGD
PMID:20463177
RGD:8698653
NCBI chr 1:72,346,576...72,434,112
Ensembl chr 1:72,346,586...72,434,111
G
Ccl11
C-C motif chemokine ligand 11
ISO
RGD
PMID:11991282
RGD:4145442
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
G
Cftr
cystic fibrosis transmembrane conductance regulator
susceptibility
ISO
DNA:deletion: :F508del(human) associated with pulmonary disease chronic obstructive; DNA:missense mutation:exon:p.R75Q(human)
RGD
PMID:10767489 PMID:15463907
RGD:4140484 , RGD:4140475
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
DNA:SNPs: :multiple (human)
RGD
PMID:19386687
RGD:4891509
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:15928955
RGD:4142512
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
DNA:polymorphism (human)
RGD
PMID:14593914
RGD:4889126
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Edn1
endothelin 1
IEP
Chronic Allergic Airway Inflammation; protein:increased secretion:bronchoalveolar lavage (mouse)
RGD
PMID:18631350
RGD:4145074
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Gc
vitamin D binding protein
susceptibility
ISO
RGD
PMID:12096683
RGD:5129516
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
Gstm1
glutathione S-transferase, mu 1
severity
ISO
DNA:deletion: : DNA:deletion, haplotype: : (human)
RGD
PMID:9187680 PMID:15125256
RGD:4142513 , RGD:12798508
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstt1
glutathione S-transferase, theta 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:15928955
RGD:4142512
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:bronchial epithelium (rat)
RGD
PMID:19507274
RGD:2308951
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Il10
interleukin 10
ISO
protein:decreased expression:lung
RGD
PMID:19507274
RGD:2308951
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il13
interleukin 13
ISO
protein:increased expression:Respiratory Mucosa
RGD
PMID:14582911
RGD:4759835
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il15
interleukin 15
ISO
mRNA, protein:increased expression:lung
RGD
PMID:11742275
RGD:4990461
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
G
Mpo
myeloperoxidase
ISO
protein:increased expression:lung
RGD
PMID:11798689
RGD:5130990
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Nos2
nitric oxide synthase 2, inducible
ISO
RGD
PMID:19938219
RGD:4891494
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Npy
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9731035
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19263519
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Adipoq
adiponectin, C1Q and collagen domain containing
IMP
RGD
PMID:20935231
RGD:5686887
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Ager
advanced glycosylation end product-specific receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30659203
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Alb
albumin
ISO
RGD
PMID:24365562
RGD:11035274
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Bloc1s6
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin
IAGP
OMIM:130700
MouseDO
NCBI chr 2:122,580,425...122,591,407
Ensembl chr 2:122,580,423...122,591,395
G
Ccl11
C-C motif chemokine ligand 11
disease_progression
ISO
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:lung
RGD
PMID:17983873
RGD:4145393
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
G
Ccl2
C-C motif chemokine ligand 2
disease_progression
ISO
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:sputum
RGD
PMID:20966041
RGD:4891458
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccr5
C-C motif chemokine receptor 5
IMP ISO IEP
protein:increased expression:lung, lymphocyte (human) mRNA, protein:increased expression:lung (mouse)
RGD
PMID:17883726 PMID:15526056 PMID:16284650
RGD:4892090 , RGD:4892104 , RGD:4892098
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Chi3l1
chitinase 3 like 1
IMP
RGD
PMID:20656949
RGD:4892658
NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919
G
Clptm1l
CLPTM1-like
severity
ISO
associated with smoking; DNA:SNP:intron:rs31489(human)
RGD
PMID:21622582
RGD:150530642
NCBI chr13:73,752,121...73,768,758
Ensembl chr13:73,752,125...73,768,724
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
RGD
PMID:19537526
RGD:11039438
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Cx3cl1
C-X3-C motif chemokine ligand 1
IEP
RGD
PMID:18772344
RGD:4891888
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
mRNA:increased expression:lung
RGD
PMID:17023518
RGD:5135245
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
protein:increased expression:lung, lymphocyte
RGD
PMID:15526056
RGD:4892104
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl3
C-X-C motif chemokine ligand 3
IEP
mRNA:increased expression:lung
RGD
PMID:17023518
RGD:5135245
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cxcl5
C-X-C motif chemokine ligand 5
IEP
mRNA:increased expression:lung
RGD
PMID:17023518
RGD:5135245
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
G
Cxcl9
C-X-C motif chemokine ligand 9
ISO
protein:increased expression:lung, lymphocyte
RGD
PMID:15526056
RGD:4892104
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:15526056
RGD:4892104
NCBI chr X:100,775,141...100,777,753
Ensembl chr X:100,775,141...100,777,875
G
Cyp2a5
cytochrome P450, family 2, subfamily a, polypeptide 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12832682
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
G
Defb1
defensin beta 1
IEP
mRNA:decreased expression:lung
RGD
PMID:18699806
RGD:4892249
NCBI chr 8:22,266,571...22,285,201
Ensembl chr 8:22,266,615...22,285,201
G
Ednra
endothelin receptor type A
ISO
RGD
PMID:19897563
RGD:4892307
NCBI chr 8:78,389,658...78,451,081
Ensembl chr 8:78,389,660...78,451,093
G
Egr1
early growth response 1
resistance
IEP ISO IMP
associated with Tobacco Use Disorder;protein:increased expression:lung, epithelial cell (mouse) mRNA, protein:increased expression:lung (human)
RGD
PMID:16601242 PMID:11021835 PMID:18830406
RGD:5131892 , RGD:5131973 , RGD:5131853
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
G
Elane
elastase, neutrophil expressed
ISO
RGD
PMID:12186827
RGD:10450557
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
G
Eln
elastin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25106431
NCBI chr 5:134,731,449...134,776,300
Ensembl chr 5:134,731,447...134,776,177
G
Ephx1
epoxide hydrolase 1, microsomal
no_association susceptibility
ISO
associated with Pulmonary Disease, Chronic Obstructive;DNA:SNPs (human) DNA:SNPs:exons:p.Y113H (rs1051740), p.H139R (rs2234922) (human) DNA:SNP:exon:p.Y113H (rs1051740) (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9288046 PMID:20525719 PMID:10853854 PMID:9288046 PMID:12579334
RGD:4140935 , RGD:4889406 , RGD:1601065 , RGD:4889405
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Fga
fibrinogen alpha chain
ISO
protein:increased expression:plasma (rat)
RGD
PMID:20949089
RGD:11040553
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
G
Fstl1
follistatin-like 1
IAGP
OMIM:130700
MouseDO
NCBI chr16:37,597,417...37,656,878
Ensembl chr16:37,597,235...37,656,876
G
Fut8
fucosyltransferase 8
IAGP
OMIM:130700
MouseDO
NCBI chr12:77,284,878...77,522,770
Ensembl chr12:77,284,899...77,523,112
G
Gclc
glutamate-cysteine ligase, catalytic subunit
ISO
RGD
PMID:19879314
RGD:5134681
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
G
Gstm1
glutathione S-transferase, mu 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:20495862
RGD:4140927
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstm3
glutathione S-transferase, mu 3
ISO
RGD
PMID:19723343
RGD:5135041
NCBI chr 3:107,871,019...107,876,484
Ensembl chr 3:107,871,012...107,876,599
G
Gstm5
glutathione S-transferase, mu 5
ISO
RGD
PMID:19723343
RGD:5135041
NCBI chr 3:107,803,240...107,806,002
Ensembl chr 3:107,803,137...107,806,002
G
Gstp1
glutathione S-transferase, pi 1
ISO
associated with Pulmonary Disease, Chronic Obstructive;DNA:SNP (human)
RGD
PMID:20525719
RGD:4140935
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Hdac2
histone deacetylase 2
treatment
ISO IEP
mRNA,proetin:increased expression,increased activity,hyperphosphorylation,hypercarbonylation:lung:
RGD
PMID:23326540 PMID:24040961
RGD:9590245 , RGD:9590320
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
G
Hhip
Hedgehog-interacting protein
IMP
DNA:haplotype insufficiency: :
RGD
PMID:25763110
RGD:11552596
NCBI chr 8:80,692,480...80,784,637
Ensembl chr 8:80,692,480...80,784,635
G
Hmox1
heme oxygenase 1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10631150 PMID:10631150
RGD:1601606
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Il13
interleukin 13
IMP
RGD
PMID:11067861
RGD:4145652
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il17ra
interleukin 17 receptor A
IMP
RGD
PMID:21647421
RGD:5144212
NCBI chr 6:120,440,143...120,460,692
Ensembl chr 6:120,440,208...120,464,520
G
Il18
interleukin 18
IMP ISO
mRNA, protein:increased expression:respiratory system fluid/secretion, macrophage
RGD
PMID:17400729 PMID:23392573
RGD:4889590 , RGD:8655969
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1rl1
interleukin 1 receptor-like 1
treatment
IMP
associated with common cold;
RGD
PMID:30952808
RGD:40400740
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Itgb6
integrin beta 6
IMP ISO IAGP
CTD Direct Evidence: marker/mechanism OMIM:130700
CTD MouseDO RGD
PMID:12634787 PMID:12634787
RGD:737734
NCBI chr 2:60,428,636...60,553,005
Ensembl chr 2:60,428,636...60,552,987
G
Jun
jun proto-oncogene
IAGP
OMIM:130700
MouseDO
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Keap1
kelch-like ECH-associated protein 1
onset
ISO IMP
protein:increased expression:lung (human)
RGD
PMID:18559366 PMID:19520915
RGD:5134973 , RGD:6893395
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
Kl
klotho
IAGP
OMIM:130700
MouseDO
NCBI chr 5:150,876,072...150,917,282
Ensembl chr 5:150,876,072...150,917,282
G
Lox
lysyl oxidase
ISO
ClinVar Annotator: match by term: Pulmonary emphysema
ClinVar
PMID:25741868 PMID:28492532
NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939
G
Mmp12
matrix metallopeptidase 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12634787 PMID:25106431
NCBI chr 9:7,344,397...7,360,461
Ensembl chr 9:7,344,381...7,369,499
G
Mmp1a
matrix metallopeptidase 1a (interstitial collagenase)
ISO
DNA:insertion:promoter:g.-1607insG rs1799750 (human)
RGD
PMID:17363767
RGD:4890375
NCBI chr 9:7,464,141...7,476,870
Ensembl chr 9:7,464,141...7,476,857
G
Mmp1b
matrix metallopeptidase 1b (interstitial collagenase)
ISO
DNA:insertion:promoter:g.-1607insG rs1799750 (human)
RGD
PMID:17363767
RGD:4890375
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
G
Mmp2
matrix metallopeptidase 2
ISO
protein:increased activity:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25106431 PMID:19897563
RGD:4892307
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp9
matrix metallopeptidase 9
treatment
ISO
protein:increased activity:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25106431 PMID:19897563 PMID:18408070 PMID:14605041
RGD:4892307 , RGD:5130151 , RGD:8547887
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mus81
MUS81 structure-specific endonuclease subunit
IAGP
OMIM:130700
MouseDO
NCBI chr19:5,532,589...5,538,461
Ensembl chr19:5,532,373...5,538,430
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
ISO
protein:decreased expression:lung:
RGD
PMID:18559366
RGD:5134973
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
treatment
ISO
RGD
PMID:20472710
RGD:4891488
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nos2
nitric oxide synthase 2, inducible
ISO IEP IMP
protein:increased expression:lung mRNA,protein:increased expression:lung
RGD
PMID:20472710 PMID:20956973 PMID:22000010
RGD:4891488 , RGD:4891415 , RGD:5509103
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
IEP
mRNA,protein:increased expression:lung
RGD
PMID:20956973
RGD:4891415
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
ISO
mRNA:decreased expression:lung
RGD
PMID:18559366
RGD:5134973
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Pgf
placental growth factor
IEP
mRNA, protein:increased expression:lung, plasma
RGD
PMID:17023518
RGD:5135245
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
IDA
RGD
PMID:23144332
RGD:7242020
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:20472710
RGD:4891488
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptma
prothymosin alpha
IAGP
OMIM:130700
MouseDO
NCBI chr 1:86,454,442...86,458,434
Ensembl chr 1:86,454,448...86,458,434
G
Scnn1b
sodium channel, nonvoltage-gated 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27982104
NCBI chr 7:121,464,261...121,517,951
Ensembl chr 7:121,464,261...121,517,737
G
Sftpc
surfactant associated protein C
susceptibility
ISO
DNA:polymorphism: :138A>C, 186A>G (human)
RGD
PMID:18038590
RGD:4144115
NCBI chr14:70,758,381...70,761,521
Ensembl chr14:70,758,389...70,761,521
G
Smo
smoothened, frizzled class receptor
IAGP
OMIM:130700
MouseDO
NCBI chr 6:29,735,480...29,761,359
Ensembl chr 6:29,735,502...29,761,364
G
Smpd3
sphingomyelin phosphodiesterase 3, neutral
ISO
protein:increased expression:lung:
RGD
PMID:20448054
RGD:10041059
NCBI chr 8:106,979,180...107,064,597
Ensembl chr 8:106,979,180...107,064,620
G
Srfbp1
serum response factor binding protein 1
ISO
ClinVar Annotator: match by term: Pulmonary emphysema
ClinVar
PMID:25741868 PMID:28492532
NCBI chr18:52,598,703...52,625,005
Ensembl chr18:52,598,765...52,625,003
G
Tacr1
tachykinin receptor 1
IMP
RGD
PMID:19445658
RGD:5147818
NCBI chr 6:82,378,990...82,537,085
Ensembl chr 6:82,379,315...82,537,085
G
Tgfb1
transforming growth factor, beta 1
severity
ISO
associated with Pulmonary Disease, Chronic Obstructive;DNA:SNPs:promoter:rs1800469, rs1982073 (human) CTD Direct Evidence: therapeutic
CTD RGD
PMID:12634787 PMID:18670143
RGD:4145272
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tlr2
toll-like receptor 2
IEP
protein:increased expression:alveolar macrophage
RGD
PMID:18399852
RGD:4145342
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
IMP IAGP
OMIM:130700
MouseDO RGD
PMID:17053835
RGD:4144170
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25106431
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all